GDF15 and prostate carcinoma: Preliminary data about the involvement of GDF15 in starvation modulation and body weight regulation dates back to 2007 when researchers proved that the injection of a GDF15-overexpressing prostate cancer cell line in xenograft models resulted in the onset of cancer cachexia syndrome, with progressive weight loss directly proportional to the blood concentration of GDF15 [77].